SCHEMBL9611892

SCHEMBL9611892

O=C(Nc1ccccc1Nc1cccc(Br)c1)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.57
KMT2A Q03164 7/20 0.57
TP53 P04637 1/20 0.57
SIRT2 Q8IXJ6 2/20 0.56
KCNK3 O14649 2/20 0.54
KCNK9 Q9NPC2 2/20 0.54
MAPT P10636 5/20 0.54
LMNA P02545 1/20 0.51
HPGD P15428 1/20 0.51
ALOX12 P18054 1/20 0.51
HTT P42858 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
TSHR P16473 2/20 0.50
ALDH1A1 P00352 1/20 0.50
RXFP1 Q9HBX9 1/20 0.50
ABL1 P00519 1/20 0.50
RIN1 Q13671 1/20 0.50
CYP1A2 P05177 2/20 0.49
NPC1 O15118 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17834297 0.91 MEN1 (0.57) MEN1KMT2ATP53SIRT2KCNK3
SCHEMBL28199719 0.87 KCNK9 (0.58) MEN1KMT2ATP53KCNK3KCNK9
SCHEMBL22191811 0.84 MEN1 (0.78) MEN1KMT2ATP53KCNK3KCNK9
SCHEMBL6140750 0.84 SIRT2 (0.59) MEN1KMT2ATP53SIRT2KCNK3
SCHEMBL16442425 0.84 MAPT (0.62) MEN1KMT2ATP53KCNK3KCNK9
SCHEMBL338138 0.83 MEN1 (0.67) MEN1KMT2ATP53SIRT2MAPT
SCHEMBL339194 0.83 MEN1 (0.71) MEN1KMT2ATP53SIRT2MAPT
SCHEMBL15770775 0.82 MEN1 (0.53) MEN1KMT2ATP53SIRT2KCNK3
SCHEMBL14339391 0.81 EGFR (0.54) MEN1KMT2ATP53MAPTLMNA
SCHEMBL14137199 0.80 EGFR (0.57) MEN1KMT2AMAPTLMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3230404-B1 AMBIPOLAR HOST MATERIALS AND THEIR USE CYNORA GMBH (DE) 2020-02-05 EP disclosed
US-RE47654-E1 Organic electroluminescence device IDEMITSU KOASN CO., LTD. (JP) 2019-10-22 US disclosed
US-RE47654-E1 Organic electroluminescence device IDEMITSU KOASN CO., LTD. (JP) 2019-10-22 US disclosed
WO-2016091887-A2 AMBIPOLAR HOST MATERIALS AND USE THEREOF CYNORA GMBH (DE) 2016-06-16 WO disclosed
US-9126943-B2 Nitrogenated heterocyclic ring derivative and organic electroluminescent element comprising same IDEMITSU KOSAN CO., LTD. (JP) 2015-09-08 US disclosed
US-9126943-B2 Nitrogenated heterocyclic ring derivative and organic electroluminescent element comprising same IDEMITSU KOSAN CO., LTD. (JP) 2015-09-08 US disclosed
EP-2525425-B1 ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO (JP) 2014-10-15 EP disclosed
US-8803420-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2014-08-12 US disclosed
US-8803420-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2014-08-12 US disclosed
US-8803420-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2014-08-12 US disclosed
EP-2525425-A1 ORGANIC ELECTROLUMINESCENT ELEMENT Idemitsu Kosan Co., Ltd. (JP) 2012-11-21 EP disclosed
US-20120153268-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-21 US disclosed
US-20120153268-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-21 US disclosed
US-20120153268-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-21 US disclosed
US-20120132899-A1 NITROGENATED HETEROCYCLIC RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-05-31 US disclosed
US-20120132899-A1 NITROGENATED HETEROCYCLIC RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120132899-A1 NITROGENATED HETEROCYCLIC RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME H1-2, L1CAM, H1-0 MEN1 822/4885KMT2A 1153/4885TP53 3568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.